ArticleBritish journal of cancer2024

A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.

Howard A Burris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.